NDC 81033-412-30 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-412
- Requested NDC
- 81033-412-30
- Package NDCs from labels
- 81033-412-15, 81033-412-51, 81033-412-50, 81033-412-30, 81033-412-32, 81033-412-34
- Manufacturer
- Kesin Pharma
- Effective date
- 2024-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Kesin Pharma | Kesin Pharma | 2024-12-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-412-15 | Potassium Chloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 81033-412-30 | Potassium Chloride | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 81033-412-32 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-34 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 | |
| 81033-412-50 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-51 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-412-15 | ML - Milliliter | 81033-412 | bbfbf218-c6fa-4f1f-a0b0-fd6c48577135 | 1 | 2024-08-12 |
| 81033-412-30 | ML - Milliliter | 81033-412 | b5400981-8240-485c-9d9f-87593850377e | 1 | 2024-08-12 |
| 81033-412-32 | ML - Milliliter | 81033-412 | 1d5cbd7d-98e5-4435-a285-be3bbff8b14a | 1 | 2024-08-12 |
| 81033-412-34 | ML - Milliliter | 81033-412 | ee33d2e1-7700-4f90-a7b5-9808c406891d | 1 | 2024-09-09 |
| 81033-412-50 | ML - Milliliter | 81033-412 | 3ec55d88-9e5c-430c-a4e9-fd74b75400de | 1 | 2024-08-12 |
| 81033-412-51 | ML - Milliliter | 81033-412 | a4c9fc82-8b5d-4db7-8def-ac8c2c3d5a44 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WINTER BLEND | ECHINACEA (ANGUSTIFOLIA), UVA-URSI, BAPTISIA TINCTORIA, CONVALLARIA MAJALIS, KALI MURIATICUM, PINUS SYLVESTRIS, THUJA OCCIDENTALIS, BRYONIA, CROTALUS HORRIDUS, LACHESIS MUTUS, SELENIUM METALLICUM, VISCUM ALBUM | Energique, Inc. | ff696389-bad5-463a-be99-e92e86250e86 | 2024-07-12 | Warnings | 660YQ98I10 |
| Zenibell Snail IntensiveCream | GLYCERIN | MISOCOS | 97c19dca-237c-c968-e053-2a95a90aeae7 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive Toner | GLYCERIN | MISOCOS | 97c1b556-824d-bef7-e053-2a95a90ae1f2 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell | GLYCERIN | MISOCOS | 980fcaea-27ba-da49-e053-2995a90ad506 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell 24k Gold Serum | GLYCERIN | MISOCOS | a17b2c6e-9db8-bae4-e053-2a95a90adcf6 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Bunnies Bum Soothing Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | FloCal Distributors LLC | 1c81582c-7ece-182f-e063-6294a90a8fbc | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive | GLYCERIN | MISOCOS | 97747267-26f1-d06f-e053-2a95a90ab087 | 2024-07-04 | Warnings | PDC6A3C0OX |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | 660YQ98I10 |
| ABREVA Rapid Pain Relief | GLYCERIN, LIDOCAINE | Haleon US Holdings LLC | 65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d | 2024-06-20 | Warnings | PDC6A3C0OX |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | ad42a7e3-84ea-390d-e053-2a95a90a3a32 | 2024-06-14 | Warnings | 059QF0KO0R |
| MegaBabe Butt Stuff Hemorrhoidal | COCOA BUTTER, GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE | MEGABABE, LLC | 01c156ff-69f9-4d5e-a9ea-abbc52d4afff | 2024-06-12 | Warnings | PDC6A3C0OX |
| KALI MUR | KALI MUR | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | 1a3522bc-3d43-ea96-e063-6394a90aa2cc | 2024-06-06 | Warnings | 660YQ98I10 |
| Eyes Alive Eye Wash | WATER | RIVIERA PHARMA INC | 081079f4-1c06-4054-b771-00fedaa666f6 | 2024-06-05 | Warnings | 059QF0KO0R |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Proficient Rx LP | c53d1db5-1c9e-4289-a2a2-961e0dd56f32 | 2024-06-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER | Becton Dickinson and Company | 6e43c5a3-dad2-49ed-b500-964cb4563cc9 | 2024-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Bryant Ranch Prepack | d396477a-6b15-4782-9c85-b9663b83c484 | 2024-05-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride in Lactated Ringers and Dextrose | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | dbed53b7-0109-4561-8342-0178ec8c64b0 | 2024-05-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 1b912c7e-f005-4af4-b683-083440964249 | 2024-05-22 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | XLCare Pharmaceuticals, Inc. | 7fd82f08-8ad0-4ee2-8eb6-5c973f98baee | 2024-05-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 7a220e87-ff72-417b-bc45-90a37b7f2aa6 | 2024-05-21 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.